Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-20-001115
Filing Date
2020-02-13
Accepted
2020-02-13 17:09:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8472657_sc13g-a.htm SC 13G/A 77952
  Complete submission text file 0000919574-20-001115.txt   79344
Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2460
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

EIN.: 202924429 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88042 | Film No.: 20611924
SIC: 2834 Pharmaceutical Preparations